Arcadis NV
OTC:ARCVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcadis NV
OTC:ARCVF
|
NL |
|
Nick Scali Ltd
F:NJN
|
AU |
|
T
|
Teradyne Inc
F:TEY
|
US |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
F:RER1
|
IT |
|
Ryman Healthcare Ltd
F:RH70
|
NZ |
|
C
|
CME Group Inc
F:MX4A
|
US |
|
Tenaris SA
F:TW10
|
LU |
|
A
|
AXA SA
PAR:CSNV
|
FR |
|
D
|
Dell Technologies Inc
F:12DA
|
US |
|
C
|
Cencora Inc
XMUN:ABG
|
US |
|
K
|
Kuehne und Nagel International AG
XMUN:KNIA
|
CH |
|
C
|
Continental AG
XBER:CON
|
DE |
|
Medicover AB
OTC:MCVEY
|
SE |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
Intrinsic Value
The intrinsic value for 
Arcadis NV (ARCVF) under the Base Case is hidden
USD.
Compared with the current market price of 40.68 USD, the stock appears hidden
.
ARCVF looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ARCVF is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Arcadis NV.
The intrinsic value for Arcadis NV (ARCVF) under the Base Case is hidden USD.
Compared with the current market price of 40.68 USD, the stock appears hidden.
